ARNALDI, GIORGIO
 Distribuzione geografica
Continente #
AS - Asia 2.921
NA - Nord America 2.362
EU - Europa 2.321
SA - Sud America 586
AF - Africa 68
OC - Oceania 3
Totale 8.261
Nazione #
US - Stati Uniti d'America 2.281
SG - Singapore 1.000
RU - Federazione Russa 856
CN - Cina 740
IT - Italia 497
BR - Brasile 481
HK - Hong Kong 390
PL - Polonia 272
VN - Vietnam 268
FR - Francia 196
DE - Germania 171
BD - Bangladesh 143
FI - Finlandia 109
JP - Giappone 81
NL - Olanda 61
IN - India 55
GB - Regno Unito 52
KR - Corea 47
MX - Messico 36
IQ - Iraq 32
TR - Turchia 30
AR - Argentina 27
CA - Canada 24
MA - Marocco 21
VE - Venezuela 21
ID - Indonesia 20
EC - Ecuador 18
AT - Austria 16
SE - Svezia 15
ES - Italia 14
MY - Malesia 13
SA - Arabia Saudita 13
JO - Giordania 12
PK - Pakistan 12
ZA - Sudafrica 12
IR - Iran 11
UA - Ucraina 11
UZ - Uzbekistan 11
IE - Irlanda 10
KE - Kenya 10
CO - Colombia 9
GR - Grecia 9
PY - Paraguay 9
PE - Perù 8
AZ - Azerbaigian 7
CI - Costa d'Avorio 7
CR - Costa Rica 6
DZ - Algeria 6
BO - Bolivia 5
PA - Panama 5
PH - Filippine 5
TW - Taiwan 5
CH - Svizzera 4
CL - Cile 4
LT - Lituania 4
NP - Nepal 4
RO - Romania 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
DK - Danimarca 3
EG - Egitto 3
ET - Etiopia 3
UY - Uruguay 3
AL - Albania 2
AU - Australia 2
BE - Belgio 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
KH - Cambogia 2
KZ - Kazakistan 2
MM - Myanmar 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LI - Liechtenstein 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PG - Papua Nuova Guinea 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.258
Città #
Singapore 587
San Jose 503
Hong Kong 382
Ashburn 251
Zgierz 250
Hefei 200
Moscow 139
Beijing 123
Lauterbourg 118
Council Bluffs 113
Helsinki 84
Ho Chi Minh City 79
Santa Clara 78
Los Angeles 76
Palermo 76
Tokyo 75
Hanoi 72
Dallas 63
Fairfield 63
Buffalo 48
Rome 47
São Paulo 46
New York 45
Redondo Beach 40
Ludwigshafen am Rhein 38
Chandler 35
Seattle 32
Milan 28
Wilmington 27
Woodbridge 27
Cambridge 23
Houston 20
Ann Arbor 19
Amsterdam 18
Paris 18
Lappeenranta 17
Nuremberg 17
Chicago 16
Frankfurt am Main 16
Haiphong 16
Columbus 15
Da Nang 15
Hangzhou 15
London 15
Rio de Janeiro 15
Warsaw 15
Guangzhou 14
Orem 14
Chennai 13
Denver 13
Brooklyn 12
Casablanca 12
Des Moines 12
Naples 12
San Francisco 12
Amman 11
Atlanta 11
Boardman 11
Istanbul 11
Shijiazhuang 11
Brasília 10
Dublin 10
Düsseldorf 10
Erbil 10
Bari 9
Guayaquil 9
Mexico City 9
Mumbai 9
Nairobi 9
Phoenix 9
Poplar 9
Shanghai 9
Tashkent 9
Vienna 9
Baghdad 8
Falls Church 8
Medford 8
Montreal 8
Munich 8
San Diego 8
Abidjan 7
Altamura 7
Biên Hòa 7
Dhaka 7
Florence 7
Porto Sant'Elpidio 7
Princeton 7
The Dalles 7
West Jordan 7
Zhengzhou 7
Can Tho 6
Curitiba 6
Johannesburg 6
Lawrence 6
Porto Alegre 6
Quito 6
Seoul 6
Stockholm 6
Tianjin 6
Baku 5
Totale 4.491
Nome #
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome 220
Pathophysiology of dyslipidemia in Cushing's syndrome 209
Extracellular vesicles as a novel immunotherapeutic strategy in hashimoto’s thyroiditis: advances in targeted delivery technologies 191
The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence” 166
Amine-Functionalized Gellan Gum-Based Hydrogel Loaded with Adipose Stem Cell-Derived Small Extracellular Vesicles: An In Vitro Proof of Concept for Enhancing Diabetic Foot Ulcer Healing 150
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 150
USE OF HUMAN MESENCHYMAL STEM CELLS-DERIVED EXTRACELLULAR VESICLES AND BIOCOMPATIBLE GELLAN GUM SCAFFOLDS FOR DIABETIC FOOT ULCERS HEALING 148
CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY VS. DUAL-RELEASE HYDROCORTISONE: EFFECTS ON INFLAMMATION AND IMMUNE PROFILE IN PATIENTS WITH PRIMARY ADRENAL INSUFFICIENCY AND IMPLICATIONS OF THERAPY RESPONSE PREDICTORS 147
Loss of WT1 Drives Adaptive Plasticity in CCDC6-RET Selpercatinib-Resistant Papillary Thyroid Cancer 142
POLYPHENOLS AS A POTENTIAL STRATEGY IN OVERCOMING THERAPY RESISTANCE IN ANAPLASTIC THYROID CANCER THROUGH THE SOX2-SOX17 MOLECULAR SWITCH 137
Effects of osilodrostat and metyrapone on 2D and 3D models of adrenocortical carcinoma cell lines viability: preliminary results 126
The promising approach of 3D bioprinting for diabetic foot ulcer treatment: A concise review of recent developments 125
Effects of the ketogenic diet compared to the mediterranean diet in patients with acromegaly 111
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 108
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome 107
Glucocorticoid excess and COVID-19 disease 105
Obesity: a disease of the ponderostat and the regulation of energy balance 104
AME position statement on adrenal incidentaloma 102
Approach to the patient with possible Cushing's syndrome 100
In situ application of xyloglucan hydrogels and extracellular vesicles from amniotic stem cells for diabetic foot ulcer healing. 93
Dual-release hydrocortisone treatment improves serum and peripheral blood mononuclear cell inflammatory and immune profiles in patients with autoimmune primary adrenal insufficiency 93
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors 90
Acromegalia e Ancona: un fil rouge lungo trecento anni, da Amato Lusitano ad Augusto Tamburini 88
New treatment guidelines on Cushing's disease 88
Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors 87
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 85
Psychometric properties of the Italian version of the Revised Temperament and Character Inventory (TCI-140) in adults and older adults with cancer managed in outpatient settings 85
Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency 85
Acromegaly and male sexual health 84
Ketogenic Diet in Steatotic Liver Disease: A Metabolic Approach to Hepatic Health 83
An evaluation of pharmacological options for Cushing's disease: what are the state-of-the-art options? 81
Adrenal incidentaloma 79
Possible influence of melatonin on the human prolactin circadian secretory pattern 77
Diabetes Insipidus: Novel Diagnostic Approaches 76
UNRAVELING THE POTENTIAL ROLE OF A SMALLEXTRACELLULAR VESICLE LYOPHILIZED ENRICHEDIN IMMUNE AND INFLAMMATORY REGULATOR FACTORS AS IMMUNORESPONSE MODULATOR INPATIENTS SUFFERING FROM AUTOIMMUNE THYROID DISEASES 73
Apparent mineralocorticoid excess type II 73
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome 72
Ultrasound-based detection of glucocorticoid-induced impairments of muscle mass and structure in Cushing’s disease 72
Androgens in Cushing's Syndrome 72
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications 72
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY 72
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 71
Diagnosis and complications of Cushing's syndrome: a consensus statement 70
A venous thromboembolism risk assessment model for patients with Cushing's syndrome 69
The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study 68
Personality (at Intrapsychic and Interpersonal Level) Associated With Quality of Life in Patients With Cancer (Lung and Colon) 67
Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study 66
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 65
A novel endothelial tyrosine kinase cDNA homologous to platelet-derived growth factor receptor cDNA 65
Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma 65
Using temperament and character dimensions (TCI) to analyze the personality profiles of adults and older adults with cancer managed in outpatient settings 65
Effects of long-term treatment with human pure FSH on seminal parameters and sperm cells ultrastructure in idiopathic oligo-asthenozoospermia 64
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly 64
Adrenal incidentaloma: surgical update 63
Structural Analysis of Social Behavior: Using Cluster Analysis to Examine Intrapsychic Personality Traits Associated With Depression in Women With Breast Cancer 63
Investigation protocol: adrenal enlargement 63
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants 62
Mutational analysis of StAR gene in adrenal tumors 62
Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial 61
Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome 61
Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status 60
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas 60
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 59
Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies 59
Self image and quality of life in acromegaly 59
Safety and effectiveness of Omnitrope® in patients with growth hormone deficiency: snapshot analysis of PATRO Adults study in the Italian population 57
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome 57
Hypothalamic-Pituitary Diseases and Erectile Dysfunction 57
Advances in medical treatment of Cushing’s disease 57
Sodium alterations impair the prognosis of hospitalized patients with COVID-19 pneumonia 57
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 57
Endocrinologists at work: management of hyponatremia in clinical practice 56
Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2) 56
Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia 56
Pituitary adenomas, stem cells, and cancer stem cells: what's new? 56
Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma 55
Pachychoroid spectrum disease and choriocapillary flow analysis in patients with Cushing disease: an optical coherence tomography angiography study 54
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials 54
Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study 54
Pituitary adenoma apoplexy: Review of personal series 52
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor 52
Unusual clinical manifestation of pheochromocytoma in a MEN2A patient 52
Hypertension-induced changes of platelet-derived growth factor receptor expression in rat aorta and heart 52
Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis 52
Severe hypomagnesaemia-induced hypocalcaemia in a patient with Gitelman's syndrome 52
Sexual Dysfunctions in Men Affected by Autoimmune Addison's Disease Before and After Short-Term Gluco- and Mineralocorticoid Replacement Therapy 51
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis 51
Desmopressin test in the differential diagnosis of Pseudo-Cushing state from Cushing’s disease 51
Cushing Syndrome: The Role of MSCs in Wound Healing, Immunosuppression, Comorbidities, and Antioxidant Imbalance 51
Laurdan fluorescence: a simple method to evaluate sperm plasma membrane alterations 51
Isolation and characterization of Mesenchymal Stem Cells from pituitary tumours 50
RNA sequencing and somatic mutation status of adrenocortical tumors: novel pathogenetic insights 50
Pegvisomant in acromegaly: why, when, how 50
How to improve effectiveness of pegvisomant treatment in acromegalic patients 49
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study 49
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study 49
Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas 49
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency 49
Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome 48
First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group 48
Totale 7.800
Categoria #
all - tutte 33.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.006


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 22 9
2021/202291 6 10 6 2 7 8 9 4 13 8 6 12
2022/2023102 14 21 2 11 10 14 5 6 13 0 3 3
2023/2024801 1 8 1 1 1 209 300 17 5 11 217 30
2024/20252.384 100 212 364 152 41 53 112 144 137 222 335 512
2025/20265.612 266 249 557 582 410 680 833 624 588 331 492 0
Totale 9.260